SCHEMBL9833629

SCHEMBL9833629

CC1(C)C(=O)Nc2cc3[nH]cnc3cc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 5/20 0.44
PDE3A Q14432 5/20 0.44
PDE4A P27815 4/20 0.44
PDE4B Q07343 4/20 0.44
PDE4C Q08493 4/20 0.44
PDE4D Q08499 4/20 0.44
AURKA O14965 2/20 0.43
AURKB Q96GD4 2/20 0.43
ATAD2 Q6PL18 1/20 0.42
MAPT P10636 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
APEX1 P27695 1/20 0.42
RECQL P46063 1/20 0.42
BLM P54132 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
PDK2 Q15119 1/20 0.41
PDK4 Q16654 1/20 0.41
CYP3A4 P08684 1/20 0.39
NAMPT P43490 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9141488 0.93 PDE3B (0.50) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL9835221 0.80 KDM4E (0.37) MAPTKDM4EALDH1A1APEX1RECQL
SCHEMBL9835173 0.74 PDE3B (0.54) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL9834966 0.74 AURKA (0.56) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL9832755 0.74 ATM (0.38) MAPTKDM4EALDH1A1TDP1CYP3A4
SCHEMBL10667572 0.73 PDE3B (0.53) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL9836087 0.73 PDE3B (0.53) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10667547 0.72 RAB9A (0.33) MAPTKDM4EALDH1A1APEX1RECQL
Bromide SCHEMBL10555121 0.72 PDE3B (0.52) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL15564530 0.72 MAPT (0.47) MAPTKDM4EALDH1A1APEX1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4730003-A Tricyclic compounds for treating heart and circulatory diseases BOEHRINGER MANNHEIM GMBH (DE) 1988-03-08 US claimed
EP-0214592-B1 PYRROLOBENZIMIDAZOLES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE PRODUCTS Roche Diagnostics GmbH (DE) 1991-08-14 EP disclosed
US-4730003-A Tricyclic compounds for treating heart and circulatory diseases BOEHRINGER MANNHEIM GMBH (DE) 1988-03-08 US disclosed
EP-0214592-A2 Pyrrolobenzimidazoles, process for their preparation and medicaments containing these products Roche Diagnostics GmbH (DE) 1987-03-18 EP disclosed